FDA Letter API

Apnea Sciences Corporation

Letter data

Company
Apnea Sciences Corporation
Recipient
James Fallon | CEO | Apnea Sciences Corporation | 27121 Aliso Creek Rd | Ste 140 | Aliso Viejo | , | CA | 92656-5308 | United States
Issue date
2019-04-29
Posted date
Not available
FDA office
Center for Devices and Radiological Health
Subject
Not available
Product
Medical Devices
CMS ID
392712
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Apnea Sciences Corporation MARCS-CMS 392712 — April 29, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: United Parcel Service Product: Medical Devices Recipient: Recipient Name James Fallon Recipient Title CEO Apnea Sciences Corporation 27121 Aliso Creek Rd Ste 140 Aliso Viejo , CA 92656-5308 United States Issuing Office: Center for Devices and Radiological Health 19701 Fairchild Road Los Angeles , CA 92612 United States Dear Mr. Fallon: The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter (WL #37-13), dated 05/09/2013. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Jeffrey Wooley (Acting) Compliance Branch Director FDA/Office of Regulatory Affairs Office of Medical Device and Radiological Health Operations Division 3/West Compliance Branch Content current as of: 05/09/2019 Regulated Product(s) Medical Devices